TQB3823 tablets

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Advanced Solid TumorMetastatic Castration-resistant Prostate Cancer

Phase 1

A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Advanced Solid Tumor

Start: 2021-09-23End: 2025-10-31Target: 164Updated: 2023-07-24

To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

TerminatedNCT05405439

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Metastatic Castration-resistant Prostate Cancer

Start: 2022-08-25End: 2023-07-19Updated: 2023-11-03